ACM
TECX

ACT Capital Management’s Tectonic Therapeutic TECX Stock Holding History

ACT Capital Management’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-250
Closed -$17K – 112
2021
Q3 		$17K Hold
250
– – 0.01% 104
2021
Q2 		$27K Buy
+250
New +$29.6K 0.01% 109

Other funds holding TECX

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

ACT Capital Management's TECX Position: Q4 2021 in Review

ACT Capital Management sold out of Tectonic Therapeutic (TECX) in Q4 2021, closing a stake of 250 shares — an estimated $17K sold.

ACT Capital Management first reported a position in TECX in Q2 2021 and held it in 2 quarters. The position peaked at $27K in Q2 2021. 92 funds tracked by Wall St. Rank hold TECX as of Q4 2021.

  • ACT Capital Management reported no remaining Tectonic Therapeutic position as of Q4 2021 after selling out during the quarter.
  • ACT Capital Management sold 250 Tectonic Therapeutic shares in Q4 2021, an estimated $17K.
  • ACT Capital Management first reported a position in Tectonic Therapeutic in Q2 2021 and held it in 2 quarters.
  • ACT Capital Management's Tectonic Therapeutic position peaked at $27K in Q2 2021.
  • 92 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2021.

Based on ACT Capital Management's 13F filing for Q4 2021, filed 3 Feb 2022.